Stockscreener 앱 받기
0.62
16.22%
-0.12
시간 외 거래:
.62
Protagenic Therapeutics Inc 주식(PTIX)의 최신 뉴스
Protagenic Therapeutics, Inc.(NasdaqCM: PTIX) dropped from S&P TMI Index - MarketScreener
How Protagenic Therapeutics Inc. stock performs in high volatility markets2026 world cup usa national team group stage playmakers possession football winner prediction insights - ulpravda.ru
Protagenic Therapeutics to begin OTC trading after Nasdaq delisting - Investing.com
Protagenic Therapeutics Prepares for Nasdaq Delisting, OTC Trading - TipRanks
Protagenic Therapeutics to begin OTC trading after Nasdaq delisting By Investing.com - Investing.com India
Protagenic Therapeutics Received Notice of Delisting - TradingView — Track All Markets
Protagenic Therapeutics Inc. (PTIX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice - Livingston Daily
Support Test: Is Protagenic Therapeutics Inc Equity Warrant stock affected by interest rate hikes2025 Trade Ideas & AI Driven Price Forecasts - moha.gov.vn
Protagenic Therapeutics receives Nasdaq non-compliance letter - MSN
EPS Watch: Is Protagenic Therapeutics Inc stock a buy on dips2025 Trade Ideas & Safe Capital Growth Plans - moha.gov.vn
ETF Watch: Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong fundamentalsQuarterly Portfolio Summary & Verified High Yield Trade Plans - moha.gov.vn
Is Protagenic Therapeutics Inc. Equity Warrant stock attractive for income investorsQuarterly Growth Report & Expert Curated Trade Ideas - Улправда
Will Protagenic Therapeutics Inc. stock deliver shareholder valueJuly 2025 Breakouts & Verified Momentum Watchlists - Улправда
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th - Newswire.com
Can Protagenic Therapeutics Inc. stock hit record highs againMarket Trend Summary & Capital Efficient Trade Techniques - Улправда
Published on: 2025-12-20 04:38:52 - Улправда
Why Protagenic Therapeutics Inc. stock remains undervalued2025 Volatility Report & Low Risk Profit Maximizing Plans - Улправда
Published on: 2025-12-19 23:10:33 - Улправда
Published on: 2025-12-19 21:59:06 - Улправда
Risk Hedge: Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong fundamentalsWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - Улправда
Will Protagenic Therapeutics Inc. stock reach all time highs in 2025Earnings Growth Summary & Risk Managed Trade Strategies - DonanımHaber
Will Protagenic Therapeutics Inc. stock split attract more investors2025 Investor Takeaways & Reliable Price Breakout Signals - DonanımHaber
Will Protagenic Therapeutics Inc. stock benefit from commodity pricesMarket Volume Summary & Technical Buy Zone Confirmation - Улправда
Can Protagenic Therapeutics Inc. stock maintain growth trajectoryMarket Activity Recap & Safe Entry Trade Signal Reports - Улправда
Resistance Check: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryJuly 2025 Pullbacks & Accurate Buy Signal Alerts - Улправда
Can Protagenic Therapeutics Inc. stock attract ESG capital inflowsWeekly Profit Summary & Stock Portfolio Risk Control - Улправда
Gap Down: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryQuarterly Trade Review & Growth-Oriented Investment Plans - Улправда
Published on: 2025-12-18 16:25:19 - Улправда
Protagenic Therapeutics Inc (PTIX) - MSN
What analysts say about Protagenic Therapeutics Inc stockValue Stock Picks & Rapid Capital Gain - earlytimes.in
Protagenic reports results from phase 1 multiple-dose study of PT00114 - MSN
Taking on analysts’ expectations and winning: Protagenic Therapeutics Inc (PTIX) - setenews.com
Protagenic Therapeutics (PTIX) Shares Phase 1 Study Results for PT00114 - GuruFocus
Protagenic reports positive safety results for stress disorder drug By Investing.com - Investing.com Canada
Protagenic reports positive safety results for stress disorder drug - Investing.com
Results from Phase 1 Multiple-Dose Study of PT00114 - ACCESS Newswire
Protagenic Therapeutics (NASDAQ: PTIX) reports positive Phase 1 multiple-dose safety data for PT00114 - Stock Titan
What Makes Kalyan Jewellers India Limited Stand Out Among CompetitorsSupport and Resistance Levels & Minimal Investment Portfolio - earlytimes.in
Will Protagenic Therapeutics Inc. (MBP0) stock profit from automation waveWeekly Trade Recap & Pattern Based Trade Signal System - Newser
Is Protagenic Therapeutics Inc. (MBP0) stock a buy before new product rollout2025 Support & Resistance & Daily Profit Focused Stock Screening - Newser
Will Protagenic Therapeutics Inc. (MBP0) stock enhance shareholder valueJuly 2025 Fed Impact & Scalable Portfolio Growth Methods - Newser
Can Protagenic Therapeutics Inc. (MBP0) stock expand revenue streamsJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - Newser
How dovish Fed policy supports Protagenic Therapeutics Inc. (MBP0) stockQuarterly Market Review & Free High Return Stock Watch Alerts - Newser
Is Protagenic Therapeutics Inc. Equity Warrant stock positioned well for digital economy2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - Newser
Is Protagenic Therapeutics Inc. stock gaining market shareJuly 2025 Weekly Recap & Community Supported Trade Ideas - Newser
Can Protagenic Therapeutics Inc. (MBP0) stock attract ESG investmentsJuly 2025 Rallies & Technical Pattern Alert System - Newser
CapEx per share of Protagenic Therapeutics, Inc. – GETTEX:MBP0 - TradingView
Will Protagenic Therapeutics Inc. Equity Warrant stock attract ESG investorsMarket Sentiment Review & Daily Momentum Trading Reports - Newser
How Protagenic Therapeutics Inc. (MBP0) stock behaves in tightening cycles2025 Winners & Losers & Low Risk Investment Opportunities - Newser
Why Protagenic Therapeutics Inc. (MBP0) stock could be next leaderJuly 2025 Sentiment & Stepwise Trade Execution Plans - Newser
Protagenic Therapeutics (PTIX) Stock Analysis Report | Financials & Insights - Benzinga
How robust is Protagenic Therapeutics Inc. (MBP0) stock financial position - Newser
Why Protagenic Therapeutics Inc. (MBP0) stock is a must watch tickerMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser
28.63%
자본화:
|
볼륨(24시간):